188 related articles for article (PubMed ID: 20347930)
1. HMGA2: A pituitary tumour subtype-specific oncogene?
Fedele M; Palmieri D; Fusco A
Mol Cell Endocrinol; 2010 Sep; 326(1-2):19-24. PubMed ID: 20347930
[TBL] [Abstract][Full Text] [Related]
2. Downregulation of HMGA-targeting microRNAs has a critical role in human pituitary tumorigenesis.
Palmieri D; D'Angelo D; Valentino T; De Martino I; Ferraro A; Wierinckx A; Fedele M; Trouillas J; Fusco A
Oncogene; 2012 Aug; 31(34):3857-65. PubMed ID: 22139073
[TBL] [Abstract][Full Text] [Related]
3. PIT1 upregulation by HMGA proteins has a role in pituitary tumorigenesis.
Palmieri D; Valentino T; De Martino I; Esposito F; Cappabianca P; Wierinckx A; Vitiello M; Lombardi G; Colao A; Trouillas J; Pierantoni GM; Fusco A; Fedele M
Endocr Relat Cancer; 2012 Apr; 19(2):123-35. PubMed ID: 22199144
[TBL] [Abstract][Full Text] [Related]
4. High-mobility group A2 gene expression is frequently induced in non-functioning pituitary adenomas (NFPAs), even in the absence of chromosome 12 polysomy.
Pierantoni GM; Finelli P; Valtorta E; Giardino D; Rodeschini O; Esposito F; Losa M; Fusco A; Larizza L
Endocr Relat Cancer; 2005 Dec; 12(4):867-74. PubMed ID: 16322327
[TBL] [Abstract][Full Text] [Related]
5. HMGA proteins up-regulate CCNB2 gene in mouse and human pituitary adenomas.
De Martino I; Visone R; Wierinckx A; Palmieri D; Ferraro A; Cappabianca P; Chiappetta G; Forzati F; Lombardi G; Colao A; Trouillas J; Fedele M; Fusco A
Cancer Res; 2009 Mar; 69(5):1844-50. PubMed ID: 19223528
[TBL] [Abstract][Full Text] [Related]
6. Detection of high-mobility group proteins A1 and A2 represents a valid diagnostic marker in post-pubertal testicular germ cell tumours.
Franco R; Esposito F; Fedele M; Liguori G; Pierantoni GM; Botti G; Tramontano D; Fusco A; Chieffi P
J Pathol; 2008 Jan; 214(1):58-64. PubMed ID: 17935122
[TBL] [Abstract][Full Text] [Related]
7. The Mia/Cd-rap gene expression is downregulated by the high-mobility group A proteins in mouse pituitary adenomas.
De Martino I; Visone R; Palmieri D; Cappabianca P; Chieffi P; Forzati F; Barbieri A; Kruhoffer M; Lombardi G; Fusco A; Fedele M
Endocr Relat Cancer; 2007 Sep; 14(3):875-86. PubMed ID: 17914116
[TBL] [Abstract][Full Text] [Related]
8. Physcomitrella HMGA-type proteins display structural differences compared to their higher plant counterparts.
Lyngaard C; Stemmer C; Stensballe A; Graf M; Gorr G; Decker E; Grasser KD
Biochem Biophys Res Commun; 2008 Oct; 374(4):653-7. PubMed ID: 18662672
[TBL] [Abstract][Full Text] [Related]
9. HMGA2 induces pituitary tumorigenesis by enhancing E2F1 activity.
Fedele M; Visone R; De Martino I; Troncone G; Palmieri D; Battista S; Ciarmiello A; Pallante P; Arra C; Melillo RM; Helin K; Croce CM; Fusco A
Cancer Cell; 2006 Jun; 9(6):459-71. PubMed ID: 16766265
[TBL] [Abstract][Full Text] [Related]
10. The High Mobility Group A2 gene is amplified and overexpressed in human prolactinomas.
Finelli P; Pierantoni GM; Giardino D; Losa M; Rodeschini O; Fedele M; Valtorta E; Mortini P; Croce CM; Larizza L; Fusco A
Cancer Res; 2002 Apr; 62(8):2398-405. PubMed ID: 11956103
[TBL] [Abstract][Full Text] [Related]
11. Expression of high mobility group A proteins in oral leukoplakia.
Larsson L; Jäwert F; Magnusson B; Hasséus B; Kjeller G
Anticancer Res; 2013 Oct; 33(10):4261-6. PubMed ID: 24122990
[TBL] [Abstract][Full Text] [Related]
12. Differential Expression of HMGA1 and HMGA2 in pituitary neuroendocrine tumors.
Portovedo S; Gaido N; de Almeida Nunes B; Nascimento AG; Rocha A; Magalhães M; Nascimento GC; Pires de Carvalho D; Soares P; Takiya C; Faria MDS; Miranda-Alves L
Mol Cell Endocrinol; 2019 Jun; 490():80-87. PubMed ID: 30999005
[TBL] [Abstract][Full Text] [Related]
13. HMGA1 and HMGA2 protein expression in mouse spermatogenesis.
Chieffi P; Battista S; Barchi M; Di Agostino S; Pierantoni GM; Fedele M; Chiariotti L; Tramontano D; Fusco A
Oncogene; 2002 May; 21(22):3644-50. PubMed ID: 12032866
[TBL] [Abstract][Full Text] [Related]
14. Epidrug mediated re-expression of miRNA targeting the HMGA transcripts in pituitary cells.
Kitchen MO; Yacqub-Usman K; Emes RD; Richardson A; Clayton RN; Farrell WE
Pituitary; 2015 Oct; 18(5):674-84. PubMed ID: 25557289
[TBL] [Abstract][Full Text] [Related]
15. Altered microRNA expression profile in human pituitary GH adenomas: down-regulation of miRNA targeting HMGA1, HMGA2, and E2F1.
D'Angelo D; Palmieri D; Mussnich P; Roche M; Wierinckx A; Raverot G; Fedele M; Croce CM; Trouillas J; Fusco A
J Clin Endocrinol Metab; 2012 Jul; 97(7):E1128-38. PubMed ID: 22564666
[TBL] [Abstract][Full Text] [Related]
16. The HMGA proteins: a myriad of functions (Review).
Cleynen I; Van de Ven WJ
Int J Oncol; 2008 Feb; 32(2):289-305. PubMed ID: 18202751
[TBL] [Abstract][Full Text] [Related]
17. Macroscopic differences in HMGA oncoproteins post-translational modifications: C-terminal phosphorylation of HMGA2 affects its DNA binding properties.
Sgarra R; Maurizio E; Zammitti S; Lo Sardo A; Giancotti V; Manfioletti G
J Proteome Res; 2009 Jun; 8(6):2978-89. PubMed ID: 19317492
[TBL] [Abstract][Full Text] [Related]
18. SOM230, a new somatostatin analogue, is highly effective in the therapy of growth hormone/prolactin-secreting pituitary adenomas.
Fedele M; De Martino I; Pivonello R; Ciarmiello A; Del Basso De Caro ML; Visone R; Palmieri D; Pierantoni GM; Arra C; Schmid HA; Hofland L; Lombardi G; Colao A; Fusco A
Clin Cancer Res; 2007 May; 13(9):2738-44. PubMed ID: 17473207
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of the HMGA2 gene in transgenic mice leads to the onset of pituitary adenomas.
Fedele M; Battista S; Kenyon L; Baldassarre G; Fidanza V; Klein-Szanto AJ; Parlow AF; Visone R; Pierantoni GM; Outwater E; Santoro M; Croce CM; Fusco A
Oncogene; 2002 May; 21(20):3190-8. PubMed ID: 12082634
[TBL] [Abstract][Full Text] [Related]
20. Transgenic mice overexpressing the wild-type form of the HMGA1 gene develop mixed growth hormone/prolactin cell pituitary adenomas and natural killer cell lymphomas.
Fedele M; Pentimalli F; Baldassarre G; Battista S; Klein-Szanto AJ; Kenyon L; Visone R; De Martino I; Ciarmiello A; Arra C; Viglietto G; Croce CM; Fusco A
Oncogene; 2005 May; 24(21):3427-35. PubMed ID: 15735694
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
